Anti-Mouse EGFR/ERBB1/HER1 Antibody (7A7)
An essential tool for your biotech research needs.
This highly specific antibody targets the epidermal growth factor receptor (EGFR), also known as ERBB1 or HER1, a crucial protein involved in cell signaling pathways. Its overexpression has been linked to various cancers, making it a promising target for cancer therapy.
The Anti-Mouse EGFR/ERBB1/HER1 Antibody (7A7) is a mouse monoclonal antibody that binds to the extracellular domain of EGFR, blocking its activity and inhibiting downstream signaling. This makes it an ideal tool for studying EGFR function and its role in cancer development and progression.
With its high specificity and sensitivity, this antibody is suitable for a wide range of applications in biotech research. It can be used for Western blotting, immunoprecipitation, immunofluorescence, and flow cytometry, among others.
In addition to its use in basic research, the Anti-Mouse EGFR/ERBB1/HER1 Antibody (7A7) has also shown promising results in pre-clinical studies. It has been used to successfully inhibit tumor growth in mouse models of EGFR-overexpressing cancers, highlighting its potential as a therapeutic agent.
But that’s not all – this antibody has also been used in combination with other targeted therapies, such as EGFR inhibitors, to enhance their effectiveness and overcome drug resistance. This further demonstrates its value in the development of new and improved cancer treatments.
In summary, the Anti-Mouse EGFR/ERBB1/HER1 Antibody (7A7) is a powerful tool for studying EGFR and its role in cancer. Its high specificity, versatility, and potential for therapeutic use make it an essential addition to any biotech research arsenal. Order now and take your research to the next level.
There are no reviews yet.